Cargando…

Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma

OBJECTIVES: There is increasing evidence that systemic inflammatory response (SIR) markers are prognostic factors for various types of cancers. This is the first study to evaluate the usefulness of SIR markers for the prognosis of early-stage ovarian clear-cell carcinoma (OCCC). METHODS: We retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Kosuke, Yoshikawa, Nobuhisa, Shirakawa, Akira, Niimi, Kaoru, Suzuki, Shiro, Kajiyama, Hiroaki, Kikkawa, Fumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779610/ https://www.ncbi.nlm.nih.gov/pubmed/31576683 http://dx.doi.org/10.3802/jgo.2019.30.e85

Ejemplares similares

The Preoperative Prognostic Nutritional Index for the Prediction of Outcomes in Patients with Early-Stage Ovarian Clear Cell Carcinoma
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance
por: Yoshida, Kosuke, et al.
Publicado: (2021)

The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma
por: Kajiyama, Hiroaki, et al.
Publicado: (2020)

Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
por: Ukai, Mayu, et al.
Publicado: (2021)

Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
por: Shimbo, Akiko, et al.
Publicado: (2019)

The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours
por: Kajiyama, Hiroaki, et al.
Publicado: (2018)

Fertility-Sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear-cell carcinoma cells
por: Kawai, Yosuke, et al.
Publicado: (2018)

PRIMA-1(MET) induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells
por: YOSHIKAWA, NOBUHISA, et al.
Publicado: (2016)

Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology
por: Kajiyama, Hiroaki, et al.
Publicado: (2014)

Epidemiological overview of metastatic ovarian carcinoma: long-term experience of TOTSG database
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

Metabolome analysis reveals a diversity of cancer tissues in advanced epithelial ovarian cancer
por: Yoshida, Kosuke, et al.
Publicado: (2021)

Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
por: Nakao, Yuri, et al.
Publicado: (2020)

The Therapeutic Effects of Goreisan, a Traditional Japanese Herbal Medicine, on Lower-Limb Lymphedema after Lymphadenectomy in Gynecologic Malignancies: A Case Series Study
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
por: Sakata, Jun, et al.
Publicado: (2017)

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
por: Yoshihara, Masato, et al.
Publicado: (2019)

Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
por: Suzuki, Shiro, et al.
Publicado: (2016)

Estrogen producing ovarian fibrosarcoma: A case report
por: Miura, Mayo, et al.
Publicado: (2019)

Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2018)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity
por: Nakamura, Kenichi, et al.
Publicado: (2021)

Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer
por: Hattori, Satomi, et al.
Publicado: (2021)

Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2014)

Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma
por: Utsumi, Fumi, et al.
Publicado: (2014)

Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis
por: Ikeda, Yoshiki, et al.
Publicado: (2022)

Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma
por: Suzuki, Kazuhiro, et al.
Publicado: (2022)

Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: Two case reports
por: Suzuki, Shiro, et al.
Publicado: (2014)

A combination of circulating miRNAs for the early detection of ovarian cancer
por: Yokoi, Akira, et al.
Publicado: (2017)

Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy
por: Nakamura, Kae, et al.
Publicado: (2021)

Clinical effects of cervical conization with positive margins in cervical cancer
por: Nagao, Yukari, et al.
Publicado: (2021)

Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
por: Yoshida, Adriana, et al.
Publicado: (2020)

Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis
por: Yamashita, Yoriko, et al.
Publicado: (2013)

GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
por: LUO, CHENHONG, et al.
Publicado: (2014)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model
por: Oda, Yukari, et al.
Publicado: (2023)

Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study
por: Ikeda, Yoshiki, et al.
Publicado: (2022)

Establishment and characterization of cell lines derived from complete hydatidiform mole
por: Yamamoto, Eiko, et al.
Publicado: (2017)

Is cell block technique useful to predict histological type in patients with ovarian mass and/or body cavity fluids?
por: Maseki, Zenta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_po94im8mttkcn1cq2pjj04agj3